Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Orexin supplementation in narcolepsy treatment: A review

E. Nepovimova, J. Janockova, J. Misik, S. Kubik, A. Stuchlik, K. Vales, J. Korabecny, E. Mezeiova, R. Dolezal, O. Soukup, T. Kobrlova, NL. Pham, TD. Nguyen, J. Konecny, K. Kuca,

. 2019 ; 39 (3) : 961-975. [pub] 20181114

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc19034904

Narcolepsy is a rare, chronic neurological disease characterized by excessive daytime sleepiness, cataplexy, vivid hallucinations, and sleep paralysis. Narcolepsy occurs in approximately 1 of 3000 people, affecting mainly adolescents aged 15 to 30 years. Recently, people with narcolepsy were shown to exhibit extensive orexin/hypocretin neuronal loss. The orexin system regulates sleep/wake control via complex interactions with monoaminergic, cholinergic and GABA-ergic neuronal systems. Currently, no cure for narcolepsy exists, but some symptoms can be controlled with medication (eg, stimulants, antidepressants, etc). Orexin supplementation represents a more sophisticated way to treat narcolepsy because it addresses the underlying cause of the disease and not just the symptoms. Research on orexin supplementation in the treatment of sleep disorders has strongly increased over the past two decades. This review focuses on a brief description of narcolepsy, the mechanisms by which the orexin system regulates sleep/wake cycles, and finally, possible therapeutic options based on orexin supplementation in animal models and patients with narcolepsy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19034904
003      
CZ-PrNML
005      
20221024103938.0
007      
ta
008      
191007s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/med.21550 $2 doi
035    __
$a (PubMed)30426515
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Nepovimova, Eugenie $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic.
245    10
$a Orexin supplementation in narcolepsy treatment: A review / $c E. Nepovimova, J. Janockova, J. Misik, S. Kubik, A. Stuchlik, K. Vales, J. Korabecny, E. Mezeiova, R. Dolezal, O. Soukup, T. Kobrlova, NL. Pham, TD. Nguyen, J. Konecny, K. Kuca,
520    9_
$a Narcolepsy is a rare, chronic neurological disease characterized by excessive daytime sleepiness, cataplexy, vivid hallucinations, and sleep paralysis. Narcolepsy occurs in approximately 1 of 3000 people, affecting mainly adolescents aged 15 to 30 years. Recently, people with narcolepsy were shown to exhibit extensive orexin/hypocretin neuronal loss. The orexin system regulates sleep/wake control via complex interactions with monoaminergic, cholinergic and GABA-ergic neuronal systems. Currently, no cure for narcolepsy exists, but some symptoms can be controlled with medication (eg, stimulants, antidepressants, etc). Orexin supplementation represents a more sophisticated way to treat narcolepsy because it addresses the underlying cause of the disease and not just the symptoms. Research on orexin supplementation in the treatment of sleep disorders has strongly increased over the past two decades. This review focuses on a brief description of narcolepsy, the mechanisms by which the orexin system regulates sleep/wake cycles, and finally, possible therapeutic options based on orexin supplementation in animal models and patients with narcolepsy.
650    _2
$a zvířata $7 D000818
650    _2
$a transplantace buněk $7 D017690
650    _2
$a genetická terapie $7 D015316
650    _2
$a lidé $7 D006801
650    _2
$a narkolepsie $x farmakoterapie $x genetika $7 D009290
650    _2
$a orexiny $x terapeutické užití $7 D000068797
650    _2
$a knihovny malých molekul $x chemie $x farmakologie $7 D054852
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Janockova, Jana $u Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Misik, Jan $u Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic.
700    1_
$a Kubik, Stepan $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague 4, Czech Republic.
700    1_
$a Stuchlik, Ales $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague 4, Czech Republic.
700    1_
$a Vales, Karel $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague 4, Czech Republic.
700    1_
$a Korabecny, Jan $u Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic.
700    1_
$a Mezeiová, Eva $u Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. $7 xx0277560
700    1_
$a Dolezal, Rafael $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic. Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Soukup, Ondrej $u Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Kobrlová, Tereza, $u Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. $d 1991- $7 xx0277928
700    1_
$a Pham, Ngoc Lam $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic. Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Nguyen, Thuy Duong $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic. Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Konecny, Jan $u Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic.
700    1_
$a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic. Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
773    0_
$w MED00003265 $t Medicinal research reviews $x 1098-1128 $g Roč. 39, č. 3 (2019), s. 961-975
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30426515 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20221024103937 $b ABA008
999    __
$a ok $b bmc $g 1451564 $s 1073454
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 39 $c 3 $d 961-975 $e 20181114 $i 1098-1128 $m Medicinal research reviews $n Med Res Rev $x MED00003265
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Možnosti archivace